semaglutide weight loss rate results week by week: timeline from first dose to full results Tirzepatide and Semaglutide key differences,

Commonly reported effects include nausea, digestive discomfort, and changes in appetite, particularly during the early stages of treatment

The landmark 1998 study by Raun and colleagues described it as "the first selective growth hormone secretagogue," demonstrating potent, dose-dependent GH release in animal models with a clean hormonal profile critically, without the cortisol and prolactin spikes of earlier GHRPs

But the null finding is notable because it suggests that GLP-1 appetite suppression may already be near the ceiling of what appetite reduction can achieve, leaving little room for phentermine to add benefit

Inflammopharmacology 2013;21(3):203-211